Optical Genome Mapping Links Chromosomal Changes to Recurrent Pregnancy Loss
Separate studies led by scientists at Dartmouth Hitchcock Medical Center (DHMC) and Queens University have…
Newswire
Pfizer and Novo Vie for $10B Metsera Deal Amidst Strategic Maneuvering
In a significant turn of events, Pfizer’s $7.3 billion agreement with biotech firm Metsera has…
Merck stakes $9.2B on Cidara and its long-acting flu drug
Merck has announced a significant $9.2 billion acquisition of Cidara Therapeutics, focusing on its long-acting…
NIH’s ORIVA Marks a Shift Toward Human-Centric Research Methodologies
The recent establishment of the NIH Office of Research Integrity, Validation, and Adoption of New…
Bristol Myers Squibb and Johnson & Johnson’s Next-Generation Blood Thinner Fails Key Trial
A closely watched next-generation blood thinner being developed by Bristol Myers Squibb and Johnson &…
Magnetically Guided Microrobots Deliver Drugs with Pinpoint Accuracy
Researchers at ETH Zurich have unveiled a groundbreaking magnetically guided microrobotics system designed to navigate…
Lundbeck Initiates Bidding War for Avadel Pharmaceuticals Amidst Competitive Landscape
Avadel Pharmaceuticals has confirmed receipt of an unsolicited acquisition proposal from Lundbeck, marking the beginning…
Merck to Acquire Cidara for $9.2 Billion, Focusing on Influenza Prevention
Merck announced on Friday that it is acquiring Cidara Therapeutics for $9.2 billion, a strategic…
Merck to Acquire Cidara for $9.2 Billion, Expanding Flu Prevention Pipeline
Merck announced on Friday its intention to acquire Cidara Therapeutics, a company focused on developing…
Eli Lilly and Novo Nordisk Disown Mangoceuticals’ GLP-1RA Partnership Claim
Eli Lilly and Novo Nordisk have officially refuted claims made by Mangoceuticals regarding a purported…